Dr Reddys Laboratories Stock Buy Hold or Sell Recommendation
| RDY Stock | USD 13.60 0.39 2.79% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Dr Reddys Laboratories is 'Strong Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Dr Reddys Laboratories given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Dr Reddys Laboratories, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Dr Reddys Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as RDY and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
RDY |
Execute Dr Reddys Buy or Sell Advice
The RDY recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Dr Reddys Laboratories. Macroaxis does not own or have any residual interests in Dr Reddys Laboratories or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Dr Reddys' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Dr Reddys Trading Alerts and Improvement Suggestions
| Dr Reddys generated a negative expected return over the last 90 days | |
| Dr Reddys has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: If You Invested 10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now |
Dr Reddys Returns Distribution Density
The distribution of Dr Reddys' historical returns is an attempt to chart the uncertainty of Dr Reddys' future price movements. The chart of the probability distribution of Dr Reddys daily returns describes the distribution of returns around its average expected value. We use Dr Reddys Laboratories price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Dr Reddys returns is essential to provide solid investment advice for Dr Reddys.
| Mean Return | -0.15 | Value At Risk | -2.57 | Potential Upside | 1.90 | Standard Deviation | 1.55 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Dr Reddys historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
RDY Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Dr Reddys, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Dr Reddys Laboratories back and forth among themselves.
| Shares | Jpmorgan Chase & Co | 2024-09-30 | 1 M | State Street Corp | 2024-09-30 | 909.9 K | Wellington Management Company Llp | 2024-12-31 | 896.2 K | American Century Companies Inc | 2024-12-31 | 862.4 K | Bank Of America Corp | 2024-09-30 | 858.8 K | Mondrian Investment Partners Ltd | 2024-12-31 | 648.8 K | Goldman Sachs Group Inc | 2024-09-30 | 556 K | Panagora Asset Management Inc | 2024-12-31 | 545.7 K | Causeway Capital Management Llc | 2024-12-31 | 539.3 K | Robeco Institutional Asset Management Bv | 2024-12-31 | 11.4 M | Aikya Investment Management Ltd | 2024-12-31 | 5.6 M |
Dr Reddys Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (9.9B) | (5.3B) | (2.7B) | (18.4B) | (16.6B) | (15.8B) | |
| Dividends Paid | 4.1B | 4.1B | 5.0B | 6.6B | 7.6B | 8.0B | |
| Capital Expenditures | 12.6B | 19.0B | 18.9B | 27.4B | 31.6B | 33.1B | |
| Net Income | 19.1B | 23.6B | 60.5B | 55.7B | 64.0B | 67.2B | |
| End Period Cash Flow | 14.8B | 14.9B | 5.8B | 7.1B | 8.2B | 6.3B | |
| Change In Cash | 12.9B | 32M | (9.1B) | 1.3B | 1.5B | 1.6B | |
| Free Cash Flow | 23.1B | 9.1B | 40.0B | 18.0B | 20.7B | 21.7B | |
| Depreciation | 12.8B | 11.8B | 12.5B | 14.8B | 17.1B | 17.9B | |
| Other Non Cash Items | 2.3B | (2.7B) | (22.0B) | (21.9B) | (25.2B) | (23.9B) | |
| Change To Netincome | (4.1B) | 5.4B | 12.0B | 6.6B | 7.6B | 8.0B | |
| Investments | 4.1B | (11.2B) | (41.4B) | (40.3B) | (36.3B) | (34.4B) | |
| Net Borrowings | (15.2B) | (19.2B) | 6.1B | 2.7B | 2.5B | 2.6B |
Dr Reddys Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Dr Reddys or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Dr Reddys' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a RDY stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.16 | |
β | Beta against Dow Jones | 0.32 | |
σ | Overall volatility | 1.55 | |
Ir | Information ratio | -0.1 |
Dr Reddys Volatility Alert
Dr Reddys Laboratories exhibits very low volatility with skewness of -0.75 and kurtosis of 2.88. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Dr Reddys' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Dr Reddys' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Dr Reddys Fundamentals Vs Peers
Comparing Dr Reddys' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Dr Reddys' direct or indirect competition across all of the common fundamentals between Dr Reddys and the related equities. This way, we can detect undervalued stocks with similar characteristics as Dr Reddys or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Dr Reddys' fundamental indicators could also be used in its relative valuation, which is a method of valuing Dr Reddys by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Dr Reddys to competition |
| Fundamentals | Dr Reddys | Peer Average |
| Return On Equity | 0.18 | -0.31 |
| Return On Asset | 0.1 | -0.14 |
| Profit Margin | 0.17 % | (1.27) % |
| Operating Margin | 0.22 % | (5.51) % |
| Current Valuation | 11.39 B | 16.62 B |
| Shares Outstanding | 833.12 M | 571.82 M |
| Shares Owned By Insiders | 0.03 % | 10.09 % |
| Shares Owned By Institutions | 14.96 % | 39.21 % |
| Number Of Shares Shorted | 15.9 M | 4.71 M |
| Price To Earning | 31.58 X | 28.72 X |
| Price To Book | 3.10 X | 9.51 X |
| Price To Sales | 0.04 X | 11.42 X |
| Revenue | 279.16 B | 9.43 B |
| Gross Profit | 184.65 B | 27.38 B |
| EBITDA | 88.42 B | 3.9 B |
| Net Income | 55.68 B | 570.98 M |
| Cash And Equivalents | 2.93 B | 2.7 B |
| Cash Per Share | 208.58 X | 5.01 X |
| Total Debt | 20.02 B | 5.32 B |
| Debt To Equity | 0.12 % | 48.70 % |
| Current Ratio | 1.98 X | 2.16 X |
| Book Value Per Share | 381.36 X | 1.93 K |
| Cash Flow From Operations | 45.43 B | 971.22 M |
| Short Ratio | 7.51 X | 4.00 X |
| Earnings Per Share | 0.74 X | 3.12 X |
| Price To Earnings To Growth | 4.51 X | 4.89 X |
| Target Price | 15.54 | |
| Number Of Employees | 27.05 K | 18.84 K |
| Beta | 0.37 | -0.15 |
| Market Capitalization | 11.49 B | 19.03 B |
| Total Asset | 387.52 B | 29.47 B |
| Retained Earnings | 265.26 B | 9.33 B |
| Working Capital | 152.01 B | 1.48 B |
Dr Reddys Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as RDY . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Dr Reddys Buy or Sell Advice
When is the right time to buy or sell Dr Reddys Laboratories? Buying financial instruments such as RDY Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Dr Reddys in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Air Thematic Idea Now
Air
Companies specializing in air services and air delivery. The Air theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Air Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for RDY Stock Analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.